Microtubule Associated Protein Tau Expression as a Predictive and Prognostic Marker in a Trial Assessing Sequential Docetaxel as Adjuvant Chemotherapy for Early Breast Cancer (TACT).

TACT Trial Trialists, A. Tutt, C. Gillett, S. Pinder, R. P. A'Hern, M. Dowsett, I. O. Ellis, J. Bartlett, J. M. Bliss, S. Johnston, P. Ellis

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)523S-523S
Number of pages1
JournalCancer Research
Volume69
Issue number24
Publication statusPublished - 15 Dec 2009

Cite this